Indivior Pharmaceuticals Inc Stock Analysis & AI Score
Indivior Pharmaceuticals Inc (INDV) has an ST Score of 53.8 (B-), driven by its Profitability (A-) and held back by its Financial Strength (C-). Analysts rate it Buy with a $48.00 price target (+33.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Indivior Pharmaceuticals Inc (INDV) has an ST Score of 53.8 (B-), driven by its Profitability (A-) and held back by its Financial Strength (C-). Analysts rate it Buy with a $48.00 price target (+33.3% upside).
- Strongest
- ProfitabilityA-
- Weakest
- Financial StrengthC-
All factor grades
- ProfitabilityA-
- GrowthB+
- MomentumB
- ForecastB-
- ValuationC
- Financial StrengthC-
- Piotroski4/9
Contact
INDV stock: frequently asked questions
What is INDV's ST Score?
Indivior Pharmaceuticals Inc (INDV) has an ST Score of 53.8 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is INDV a buy, hold, or sell?
Analysts rate INDV a Buy, with a price target of $48.00 (+33.3% vs the current price). Our ST Score grades it B- (53.8/100). The ST Score is a data-driven signal, not a recommendation.
What are INDV's factor grades?
Valuation C, Profitability A-, Financial Strength C-, Momentum B, Growth B+, Forecast B-.
What is INDV's valuation grade?
Indivior Pharmaceuticals Inc (INDV) earns a valuation grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is INDV's growth grade?
Indivior Pharmaceuticals Inc (INDV) earns a growth grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is INDV's profitability grade?
Indivior Pharmaceuticals Inc (INDV) earns a profitability grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is INDV's financial strength grade?
Indivior Pharmaceuticals Inc (INDV) earns a financial strength grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for INDV?
The average analyst price target for Indivior Pharmaceuticals Inc (INDV) is $48.00 from 4 analysts, which is +33.3% versus the recent price of $36.00.
What is INDV's Piotroski score?
Indivior Pharmaceuticals Inc (INDV) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.